Skip to main content

Imported Unlicensed Medicines and Centrally Authorised Medicines intended for other EU Member States

Posted by: , Posted on: - Categories: Compliance matters, Good distribution practice, Good manufacturing practice
Various medicines in blister strips

Previously, we have reminded importers of unlicensed medicines that Centrally Authorised medicines are the subject of Marketing Authorisations from the EMA, valid in all Member States and therefore cannot be notified for import into the UK as unlicensed medicines, unless …

Too much pressure: a behavioural approach to Data Integrity (Part 2)

Chemist wearing safety glasses and using a tablet

The first post in this series described the importance of organisational behaviour on the success of data integrity control measures.  Behavioural issues are often unsuitable for technical guidance, but the Inspectorate blog provides an opportunity to address this complex issue.

Too much pressure: a behavioural approach to Data Integrity (Part 1)

Burst water pipe, leaking water

...experience. Behavioural elements of data governance An MHRA data integrity post published on 25 June 2015 acknowledged the importance of organisational behaviour on the success of data integrity control measures....

Annex 16 QP certification and batch release – frequently asked questions – part 1

Posted by: , Posted on: - Categories: Compliance matters, Good distribution practice, Good manufacturing practice

In this post you’ll find the first in a series of ‘frequently asked questions’ related to the updated EU GMP Annex 16 on QP Certification and Batch Release.

Overview of compliance management escalation processes used by the GMP Inspectorate

Iceberg on the horizon

At the GMDP Symposium 2016, Andrew Hopkins and I gave a presentation about the Inspection Action Group (IAG) and Compliance Management Team (CMT), to highlight the systems and processes in place for when compliance issues are identified at manufacturing and …